Reported Earlier, Quest Diagnostics Prices $1.85B Senior Notes Due 2027, 2029, And 2034
Reported Earlier, Quest Diagnostics Prices $1.85B Senior Notes Due 2027, 2029, And 2034
奎斯特诊疗公司早前报告的消息：发行总额为18.5亿美元的2027年、2029年和2034年到期的高级票据。
Quest Diagnostics Incorporated (NYSE:DGX) (the "Company"), a leader in diagnostic information services, today announced the pricing of a public offering of $400 million aggregate principal amount of its 4.600% senior notes due 2027 (the "2027 notes"), $600 million aggregate principal amount of its 4.625% senior notes due 2029 (the "2029 notes") and $850 million aggregate principal amount of its 5.000% senior notes due 2034 (the "2034 notes," and together with the 2027 notes and the 2029 notes, the "notes") under Quest Diagnostics' shelf registration statement.
奎斯特诊疗公司（纽交所：DGX）是一家诊断信息服务领域的领导者，今天宣布根据其搁置登记声明，发行40000万美元的4.600％优先票据（"2027票据"），发行60000万美元的4.625％优先票据（"2029票据"）和发行85000万美元的5.000％优先票据（"2034票据"，连同2027票据和2029票据共同构成"票据"）的公开发行定价。
资讯热榜
更新时间